INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 446m ago
HOUSE PTR45m ago
SEC 13F45m ago
ROBINHOOD CHAIN45m ago
Corporate insider
LA

Lenz Robert A.

DirectorCIK 0001992908

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 0
Max Insider Score21
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
LA
Lenz Robert A.Director
NBPNovaBridge Biosciences
Option exercise
M—
17.2K sh
Aug 22, 2026Aug 25, 2026
traded Aug 22, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    NovaBridge BiosciencesDirector · Aug 25, 2026
  • Insider ofevidence
    LB PHARMACEUTICALS INCDirector · Mar 10, 2026
21
LA
Lenz Robert A.Director
NBPNovaBridge Biosciences
Option exercise
M
—
7,486 sh
Aug 22, 2026
Aug 25, 2026
traded Aug 22, 2026
+3d
SEC FORM 4

Evidence

9
LA
Lenz Robert A.Director
LBRXLB PHARMACEUTICALS INC
Grant or award
A—
12.5K sh
Jun 3, 2026Jun 5, 2026
traded Jun 3, 2026
+2dSEC FORM 4

Evidence

9
LA
Lenz Robert A.Director
LBRXLB PHARMACEUTICALS INC
Grant or award
A—
20.0K sh
Mar 6, 2026Mar 10, 2026
traded Mar 6, 2026
+4dSEC FORM 4

Evidence